ArticleJournal of orthopaedic case reports2024
The Use of Botulinum Toxin in Pre-Pubic Aponeurotic Complex Injuries: A Case Report.
Article in Journal of orthopaedic case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The Use of Botulinum Toxin in Pre-pubic Aponeurotic Complex Injuries: A Case Series.Journal of orthopaedic case reports · 2025Article
- What the Radiologist Needs to Know About Sport Hernias: A Systematic Review of the Current Literature.Diagnostics (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The pre-pubic aponeurotic complex (PPAC) is a fibrous capsule which lines the anterior of the pubic symphysis. The PPAC may be injured during pelvic torsional movements and single-stance maneuvers. Case Report: This case report describes a PPAC lesion in a 23-year-old professional male athlete specializing in decathlon on a national level. The lesion was treated with US-guided infiltration therapy with botulinum toxin (BTX) and platelet-rich plasma therapy (PRPt) to the longus adductor (LA) and rectus abdominis (RA) muscles. The magnetic resonance imaging control performed at 24 weeks after BTX infiltration and PRPt showed a total restitution ad integrum of the lesion area. At a 3-year follow-up, the subject no longer complained of pain and was restored to his pre-injury level of sport. Conclusion: The distention of LA and RA obtained by BTX infiltration coupled with PRPt allowed PPAC to heal. The BTX infiltrative therapy coupled with PRPt may represent a new and promising treatment for PPAC lesions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.